Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Wallingford, Connecticut


Purpose:

A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia


Criteria:

Inclusion Criteria: - Men and women, ages 18 and older, with a worsening of schizophrenia symptoms over the past three months


NCT ID:

NCT00080327


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Wallingford, Connecticut
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.